Vaping during the COVID‐19 pandemic: NOT GOOD

4,5 Recent COVID‐19 societal/social disruption within this population resulting from loss of school and work social structure, as well as stress related home confinement parent/child interactions, are likely not conducive to a reduction in previously reported vaping activity and likely represent a correlated risk of an increase in utilization. A single JUUL e‐cigarette pod, the most popular ENDS on the market, contains as much nicotine as a pack of 20 cigarettes. 6 Daily JUUL users report using about 10 pods per month through 4 to 9 daily vaping sessions. 7 FDA approved transdermal nicotine dosing systems for smoking cessation are available in 7, 14, and 21 mg/day in over‐the‐counter packaging and may be necessary to combat nicotine withdrawal in heavy vaping/ENDS users attempting to quit. Otolaryngologists and primary care physicians are on the ambulatory front line of the COVID‐19 identification and isolation pathway for patients given the early onset of sino‐nasal unified airway symptoms and can play a significant public health role in educating the public on the risks of vaping/ENDS use during this current pandemic.